 HORSHAM, Pa., Oct. 04, 2021 GLOBE NEWSWIRE -- STRATA Skin Sciences, Inc. NASDAQ: SSKN, a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that Mr. Christopher Lesovitz, STRATAs current Controller, has been named Chief Financial officer. He succeeds Matthew Hill, who has decided to leave effective October 15, 2021 to pursue a new opportunity. Mr. Lesovitz will assume the role of Chief Financial Officer effective October 16. 